BIOA INVESTOR ALERT: Edelson Lechtzin LLP Urges BioAge Labs, Inc. (NASDAQ: BIOA) Shareholders to Consult Legal Counsel About the Impending Lead Plaintiff Deadline in the Securities Fraud Class Action

Posted on by

NEWTOWN, Pa., Jan. 8, 2025 /PRNewswire/ — Edelson Lechtzin LLP, a leading class action law firm, is investigating securities fraud claims on behalf of all investors of BioAge Labs, Inc. (NASDAQ: BIOA) who purchased stock pursuant and/or traceable to BioAge Labs’ registration statement…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.